Original articleThe effects of SAFRANAL (cas 116-26-7), a constitute of saffron, and metformin on spatial learning and memory impairments in type-1 diabetic rats: behavioral and hippocampal histopathological and biochemical evaluations
-
Add time:08/29/2019 Source:sciencedirect.com
Safranal is one of saffron constituents and has antioxidant and neuroprotective properties. Metformin is used as an anti-diabetic drug. This study was planned to investigate the separate and combined treatment effects of safranal and metformin on diabetes-induced learning and memory impairments by behavioral and hippocampal histopathological and biochemical evaluations. Diabetes was induced by intraperitoneal injection of streptozotocin (STZ), treatments with safranal (0.025, 0.1 and 0.4 mg/kg), metformin (50 and 200 mg/kg), and a combination of low doses of this chemicals were initiated after confirmation of diabetes and continued for 37 days. Blood glucose concentration was measured before and on days 15, 25 and 35 after injection of streptozotocin. Learning and memory tested using Morris Water Maze (MWM) on days 40–45 and on day 45 hippocampal specimens were collected for determination of malodialdehyde (MDA), tumor necrosis factor-alpha (TNF-α) and Caspase-3 levels and superoxide dismutase (SOD) activity. The hippocampus was also designed for light microscopy evaluation. Hyperglycemia, spatial learning and memory impairments, hippocampal neuron loss, increase of hippocampal MDA, TNF-α and caspase-3 levels and decrease of SOD activity were observed in diabetic rats. Safranal (0.1 and 0.4 mg/kg), metformin (200 mg/kg) and safranal (0.025 mg/kg) with metformin (50 mg/kg) improved the above-mentioned behavioral, histopathological and biochemical changes. Safranal and metformin and their combination improved learning and memory impairments in STZ-induced diabetic rats. Antioxidant, anti-inflammatory and antiapoptotic mechanisms might be involved. It is recommended that safranal be considered for diabetes management.
We also recommend Trading Suppliers and Manufacturers of SAFRANAL (cas 116-26-7). Pls Click Website Link as below: cas 116-26-7 suppliers
Prev:Spectroscopic and computational evaluation on the binding of SAFRANAL (cas 116-26-7) with human serum albumin: Role of inner filter effect in fluorescence spectral correction
Next:In-vitro evaluation of antioxidant, anti-elastase, anti-collagenase, anti-hyaluronidase activities of SAFRANAL (cas 116-26-7) and determination of its sun protection factor in skin photoaging) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- SAFRANAL (cas 116-26-7) and its analogs inhibit Escherichia coli ATP synthase and cell growth08/31/2019
- In-vitro evaluation of antioxidant, anti-elastase, anti-collagenase, anti-hyaluronidase activities of SAFRANAL (cas 116-26-7) and determination of its sun protection factor in skin photoaging08/30/2019
- Spectroscopic and computational evaluation on the binding of SAFRANAL (cas 116-26-7) with human serum albumin: Role of inner filter effect in fluorescence spectral correction08/28/2019
- Original articleSAFRANAL (cas 116-26-7) epoxide – A potential source for diverse therapeutic applications08/27/2019
- Research articleAnti-oxidative effects of SAFRANAL (cas 116-26-7) on immobilization-induced oxidative damage in rat brain08/26/2019
- SAFRANAL (cas 116-26-7), a constituent of saffron, exerts gastro-protective effects against indomethacin-induced gastric ulcer08/25/2019
- Modulation of amyloid fibril formation of plasma protein by saffron constituent “SAFRANAL (cas 116-26-7)”: Spectroscopic and imaging analyses08/24/2019
- Experimental and computational investigation on the molecular interactions of SAFRANAL (cas 116-26-7) with bovine serum albumin: Binding and anti-amyloidogenic efficacy of ligand08/23/2019
- Binding of SAFRANAL (cas 116-26-7) to whey proteins in aqueous solution: Combination of headspace solid-phase microextraction/gas chromatography with multi spectroscopic techniques and docking studies08/22/2019